| Project/Area Number |
59870087
|
|---|
| Research Category |
Grant-in-Aid for Developmental Scientific Research
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
応用薬理学・医療系薬学
|
|---|
| Research Institution | Kitasato University School of Medicine |
|---|
Principal Investigator |
KATORI Makoto Kitasato University School of Medicine Professor, 医学部, 教授 (50050365)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
YAMAMOTO Shozo Tokushima University School of Medicine Professor and four other memebers., 医学部, 教授 (50025607)
MUROTA Sei-itsu Tokyo Medical and Dental University School of Dentistry Professor, 歯学部, 教授 (50072989)
TSURUFUJI Susumu Tohoku University School of Pharmacy Professor, 薬学部, 教授 (40012596)
TADA Michihiko Osaka University School of Medicine Professor, 医学部, 教授 (90093434)
SATOH Kazuo Saitama Medical School, Saitama Medical Center Professor, 教授 (80010180)
|
|---|
| Project Period (FY) |
1984 – 1986
|
| Project Status |
Completed (Fiscal Year 1986)
|
| Budget Amount *help |
¥8,200,000 (Direct Cost: ¥8,200,000)
Fiscal Year 1986: ¥1,400,000 (Direct Cost: ¥1,400,000)
Fiscal Year 1985: ¥1,400,000 (Direct Cost: ¥1,400,000)
Fiscal Year 1984: ¥5,400,000 (Direct Cost: ¥5,400,000)
|
|---|
| Keywords | Assay methods for prostaglandins / Elimination of disturbing substances for assay / Assay for 11-dehydro-Thromboxane <B_2> / leukotriene / 12-HETE / 6-keto-PG【F_(1α)】 / 11-dehydro-thromboxane【B_2】 / leukotriene【B_4】 / leukotriene【C_4】 / leukotriene【D_4】 / 前処理法 / 放射免疫測定法 / ガスクロマトグラフィ質量分析法 |
|---|
| Research Abstract |
This project team, composed of speakers of assay workshop in Kyoto Prostaglandin (PG) Conference, 1984, has focused the research on the following items, according to the conclusion of the workshop.
1. Establishment of clean-up method: 6-Keto- <PGF_(la)> in a test sample of human plasma containing a known amount (1 ng) was measured as a blind sample by own method of the team members (RIA, EIA, GC-MS with or without cleaning-up) to compare cleaning method. Variation of the values was rather small, but the following criticisms were made: (1) Sep-Pak C18, which was used by most members for separation of PGs, releases by organic solvent materials, which disturb RIA and EIA. (2) Thus, Sep-Pak C18 should be used in combination with HPLC or TLC for elimination of impure substances. (3) Purity of radio-labelled compounds for testing recovery as well as a difference between calibration curves of the standard also caused variation of the values.
2. Development of enzyme-immunoassay of 11-dehydro- <TXB_2> (DH- <TXB_2> ): Enzyme-immuno-assay of DH- <TXB_2> , a metabolite of <TXB_2> , has been developed, as <TXB_2> is generated artificially. Determination with the present kit revealed that an increase in DH- <TXB_2> values during blood collection was not observed and duration of blood concentration of DH- <TXB_2> was longer than that of <TXB_2> . DH- <TXB_2> value in urine from patients of essential hypertension was well correlated to that of <TXB_2> , but TXA synthetase inhibitor attenuated DH- <TXB_2> value in rat urine only slightly.
3. Leukotriene (LT) assay method: Cleaning-up must be made before using commercial RIA kits; acidification of samples at pH 3.5, followed by separation of LTs by Sep-Pak C18, enabled us to determine <LTB_4> and immunoreactive LTs without difficulty. It should be noticeable that 12-HETE on HPLC co-migrates with that of impure materials from ethanol, indicating that caution should be taken when 12-HETE is detected.
|
